These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22510874)

  • 1. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.
    Liersch R; Gerss J; Schliemann C; Bayer M; Schwöppe C; Biermann C; Appelmann I; Kessler T; Löwenberg B; Büchner T; Hiddemann W; Müller-Tidow C; Berdel WE; Mesters R
    Blood; 2012 May; 119(22):5215-20. PubMed ID: 22510874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML.
    Powell JA; Thomas D; Barry EF; Kok CH; McClure BJ; Tsykin A; To LB; Brown A; Lewis ID; Herbert K; Goodall GJ; Speed TP; Asou N; Jacob B; Osato M; Haylock DN; Nilsson SK; D'Andrea RJ; Lopez AF; Guthridge MA
    Blood; 2009 Nov; 114(23):4859-70. PubMed ID: 19805619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia.
    Song J; Shang B; Pei Y; Shi M; Niu X; Dou L; Drokow EK; Xu F; Bai Y; Sun K
    Leuk Res; 2021 Oct; 109():106638. PubMed ID: 34116372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
    Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
    Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML.
    Schmohl JU; Nuebling T; Wild J; Kroell T; Kanz L; Salih HR; Schmetzer H
    J Investig Med; 2016 Dec; 64(8):1252-1260. PubMed ID: 27388616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
    Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low SMC1A protein expression predicts poor survival in acute myeloid leukemia.
    Hömme C; Krug U; Tidow N; Schulte B; Kühler G; Serve H; Bürger H; Berdel WE; Dugas M; Heinecke A; Büchner T; Koschmieder S; Müller-Tidow C
    Oncol Rep; 2010 Jul; 24(1):47-56. PubMed ID: 20514443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD318 (CDCP1) as novel prognostic marker in AML.
    Heitmann JS; Hagelstein I; Hinterleitner C; Roerden M; Jung G; Salih HR; Märklin M; Kauer J
    Ann Hematol; 2020 Mar; 99(3):477-486. PubMed ID: 31965270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia.
    Zhou X; Liang S; Zhan Q; Yang L; Chi J; Wang L
    Cell Death Dis; 2020 Jun; 11(6):492. PubMed ID: 32606327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia.
    Zhou J; Chen X; Zhou P; Sun X; Chen Y; Li M; Chu Y; Zhou J; Hu X; Luo Y; Yuan W; Wang G
    Biochem Biophys Res Commun; 2022 Apr; 600():29-34. PubMed ID: 35182972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.
    Herst PM; Howman RA; Neeson PJ; Berridge MV; Ritchie DS
    J Leukoc Biol; 2011 Jan; 89(1):51-5. PubMed ID: 20959411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
    Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
    Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
    Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis.
    Galli S; Zlobec I; Schürch C; Perren A; Ochsenbein AF; Banz Y
    Leuk Res; 2015 Jul; 39(7):749-56. PubMed ID: 25943033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.